530 related articles for article (PubMed ID: 23531613)
1. Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK.
White JP; Puppa MJ; Gao S; Sato S; Welle SL; Carson JA
Am J Physiol Endocrinol Metab; 2013 May; 304(10):E1042-52. PubMed ID: 23531613
[TBL] [Abstract][Full Text] [Related]
2. Lewis lung carcinoma regulation of mechanical stretch-induced protein synthesis in cultured myotubes.
Gao S; Carson JA
Am J Physiol Cell Physiol; 2016 Jan; 310(1):C66-79. PubMed ID: 26491045
[TBL] [Abstract][Full Text] [Related]
3. The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min/+) mouse.
White JP; Baynes JW; Welle SL; Kostek MC; Matesic LE; Sato S; Carson JA
PLoS One; 2011; 6(9):e24650. PubMed ID: 21949739
[TBL] [Abstract][Full Text] [Related]
4. Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia.
Puppa MJ; Gao S; Narsale AA; Carson JA
FASEB J; 2014 Feb; 28(2):998-1009. PubMed ID: 24145720
[TBL] [Abstract][Full Text] [Related]
5. Testosterone regulation of Akt/mTORC1/FoxO3a signaling in skeletal muscle.
White JP; Gao S; Puppa MJ; Sato S; Welle SL; Carson JA
Mol Cell Endocrinol; 2013 Jan; 365(2):174-86. PubMed ID: 23116773
[TBL] [Abstract][Full Text] [Related]
6. Systemic IL-6 regulation of eccentric contraction-induced muscle protein synthesis.
Hardee JP; Fix DK; Wang X; Goldsmith EC; Koh HJ; Carson JA
Am J Physiol Cell Physiol; 2018 Jul; 315(1):C91-C103. PubMed ID: 29641213
[TBL] [Abstract][Full Text] [Related]
7. Wheel running improves fasting-induced AMPK signaling in skeletal muscle from tumor-bearing mice.
Fix DK; Counts BR; Smuder AJ; Sarzynski MA; Koh HJ; Carson JA
Physiol Rep; 2021 Jul; 9(14):e14924. PubMed ID: 34270178
[TBL] [Abstract][Full Text] [Related]
8. Antagonistic control of muscle cell size by AMPK and mTORC1.
Mounier R; Lantier L; Leclerc J; Sotiropoulos A; Foretz M; Viollet B
Cell Cycle; 2011 Aug; 10(16):2640-6. PubMed ID: 21799304
[TBL] [Abstract][Full Text] [Related]
9. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
Tong JF; Yan X; Zhu MJ; Du M
J Cell Biochem; 2009 Oct; 108(2):458-68. PubMed ID: 19639604
[TBL] [Abstract][Full Text] [Related]
10. Lipid-induced mTOR activation in rat skeletal muscle reversed by exercise and 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside.
Rivas DA; Yaspelkis BB; Hawley JA; Lessard SJ
J Endocrinol; 2009 Sep; 202(3):441-51. PubMed ID: 19574345
[TBL] [Abstract][Full Text] [Related]
11. JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.
Bonetto A; Aydogdu T; Jin X; Zhang Z; Zhan R; Puzis L; Koniaris LG; Zimmers TA
Am J Physiol Endocrinol Metab; 2012 Aug; 303(3):E410-21. PubMed ID: 22669242
[TBL] [Abstract][Full Text] [Related]
12. Time course changes in signaling pathways and protein synthesis in C2C12 myotubes following AMPK activation by AICAR.
Williamson DL; Bolster DR; Kimball SR; Jefferson LS
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E80-9. PubMed ID: 16760336
[TBL] [Abstract][Full Text] [Related]
13. Sex differences in the relationship of IL-6 signaling to cancer cachexia progression.
Hetzler KL; Hardee JP; Puppa MJ; Narsale AA; Sato S; Davis JM; Carson JA
Biochim Biophys Acta; 2015 May; 1852(5):816-25. PubMed ID: 25555992
[TBL] [Abstract][Full Text] [Related]
14. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
[TBL] [Abstract][Full Text] [Related]
15. The role of AMPK/mTOR/S6K1 signaling axis in mediating the physiological process of exercise-induced insulin sensitization in skeletal muscle of C57BL/6 mice.
Liu X; Yuan H; Niu Y; Niu W; Fu L
Biochim Biophys Acta; 2012 Nov; 1822(11):1716-26. PubMed ID: 22846606
[TBL] [Abstract][Full Text] [Related]
16. Cachexia Disrupts Diurnal Regulation of Activity, Feeding, and Muscle Mechanistic Target of Rapamycin Complex 1 in Mice.
Counts BR; Hardee JP; Fix DK; Vanderveen BN; Montalvo RN; Carson JA
Med Sci Sports Exerc; 2020 Mar; 52(3):577-587. PubMed ID: 32058469
[TBL] [Abstract][Full Text] [Related]
17. Activation of AMP-activated protein kinase is involved in vincristine-induced cell apoptosis in B16 melanoma cell.
Chen MB; Shen WX; Yang Y; Wu XY; Gu JH; Lu PH
J Cell Physiol; 2011 Jul; 226(7):1915-25. PubMed ID: 21506122
[TBL] [Abstract][Full Text] [Related]
18. Cachectic skeletal muscle response to a novel bout of low-frequency stimulation.
Puppa MJ; Murphy EA; Fayad R; Hand GA; Carson JA
J Appl Physiol (1985); 2014 Apr; 116(8):1078-87. PubMed ID: 24610533
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ER stress and unfolding protein response pathways causes skeletal muscle wasting during cancer cachexia.
Bohnert KR; Gallot YS; Sato S; Xiong G; Hindi SM; Kumar A
FASEB J; 2016 Sep; 30(9):3053-68. PubMed ID: 27206451
[TBL] [Abstract][Full Text] [Related]
20. Suppression of the mTORC1/STAT3/Notch1 pathway by activated AMPK prevents hepatic insulin resistance induced by excess amino acids.
Li H; Lee J; He C; Zou MH; Xie Z
Am J Physiol Endocrinol Metab; 2014 Jan; 306(2):E197-209. PubMed ID: 24302004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
